Fig. 1: Patient characteristics in comparison to the corresponding cfDNA concentrations and total CTC counts. | Oncogene

Fig. 1: Patient characteristics in comparison to the corresponding cfDNA concentrations and total CTC counts.

From: Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities

Fig. 1

For each patient, the detectable CTC count and cfDNA concentration were examined, possibly affected by the therapy status, including treatment prior to study enrollment and the time span (Δt) between the last therapy (Tx) and liquid biopsy collection (LB). CT chemotherapy, IT immunotherapy, RT radiotherapy, SURG surgery, TT targeted therapy, mo months. ‡available NGS data from whole genome amplified CTCs.

Back to article page